Other initiatives include a project to validate antibodies ... to see if it can be applied to the companion animal market,” says Koehn. As biotech companies struggle for funding and corporate ...

The animal biotech sector reached a landmark in February ... in the US and 3,500 in Europe require antithrombin therapy, and project a peak of $40–50 million annually in the US, perhaps double ...